NMJ Disorders Flashcards

1
Q

Neuromuscular disorders are characterized by

___ weakness.

A

insidious, slowly progressive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Proximal weakness is characteristic of ___ while distal is characteristic of ___, and facial weakness is characteristic of ___

A

muscle disorders, neuropathy, cranial disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Muscle necrosis can be diagnosed by ordering ___; the highest levels are seen in ___

A

creatinine kinase; myoglobinuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Charcot Marie Tooth disease is a ___ (broad classification)

A

hereditary polyneuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

___ are seen in about 30% of AMLS patients

A

Cognitive defects, eg speech issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ALS is characterized by ___ resulting from degeneration of brainstem and spinal cord lower motor neurons

A

progressive weakness and wasting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ALS is characterized by progressive weakness and wasting resulting from degeneration of ___

A

brainstem and spinal cord lower motor neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ALS is characterized by progressive weakness and wasting resulting from ___ of brainstem and spinal cord lower motor neurons

A

degeneration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

___ muscles are often spared in ALS

A

Extraocular and facial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

___ (medication) has been shown to slow the progression of ALS slightly and extend life for 3 month

A

Riluzole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CMT 1 and 2 are differentiated based on the speed of ___ and the degeneration of ___ vs ___

CMT can be divided into one group with
slow nerve conduction velocities (NCVs) and pathological evidence of a hypertrophic
demyelinating neuropathy (CMT type 1) and a second group with relatively normal nerve
conduction velocities and axonal degeneration (CMT2).

A

Nerve Conduction Velocities (NCVs) - 1 is slow, 2 is fast

hypertrophic demyelinating neuropathy (type 1)
axonal degernation (type 2)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Letters after the CMT numbers refer to ___

A

the specific genes affected

Presently mutations causing inherited neuropathies have been identified in more than 50 genes and at more than 44 distinct loci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CMT1A is a duplication in the gene ___, also implicated in HNPP (but via deletion)

A

PMP22

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The cutoff for NCVs between demyelinating (1) and axonal (2) forms of CMT is about

A

35-45m/sec

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

___ is the most common cause of neuropathies in the Western world, with distal sensory or sensorimotor polyneuropathy being the most common manifestations

A

Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diabetes is the most common cause of neuropathies in the Western world, with ___ being the most common manifestations

A

distal sensory or sensorimotor polyneuropathy

17
Q

___ is characterized by acute onset of asymmetrical proximal weakness and pain of the legs, often occurring at the onset of diabetes and accompanied by weight loss

A

Lumbosacral plexopathy

18
Q

Lumbosacral plexopathy is characterized by acute onset of asymmetrical proximal weakness and pain of the legs, often occurring at the ___ and accompanied by weight loss

A

onset of diabetes

19
Q

MG is an autoimmune disorder of the ___

A

post-synaptic ACh receptor

20
Q

85% of Myasthenia Gravis patients have ___ and 10% have a ___

A

thymic enlargement; thymoma

21
Q

___ symptoms are present initially in 50% of myasthenia gravis patients and eventually in 90%.

A

Ocular symptoms including ptosis, diplopia and blurred vision

22
Q

Diagnosis of myasthenia gravis is made via ___ tests

A

Serum AChR antibodies in 85%, MUSK antibodies in the rest

23
Q

Edrophonium is a ___, treatment for ___

A

cholinesterase inhibitor; myasthenia gravis

24
Q

Duchenne and Becker muscular dystrophy have X-linked deletions, duplications and point mutationsin the protein ___

A

dystrophin

25
Q

Of the muscular dystrophies, ___ has a later onset, better survival, and more benign prognosis

A

Becker

26
Q

Key findings in both Duchenne and Becker muscular dystrophy include ___

A

proximal muscle weakness, calf muscle hypertrophy, and Gower’s maneuver (get up)

27
Q

Duchenne and Becker are diagnosed clinically by the present of the Gower maneuver as well as elevated ___

A

creatinine kinase

28
Q

All motor neuron, neuromuscular junction and muscle diseases have no ___ changes accompanying the
weakness.

A

sensory

29
Q

Coexisting sensory complaints with muscle/motor neuron/NMJ disease suggest ___, ___, or ___.

A

nerve root, plexus or peripheral nerve disorder.

30
Q

Normal creatine kinase is ___

A

25-90 U/L for men, 10-70 U/L for women because they have lower muscle mass

31
Q

Normal NCS are ___

A

40m/sec in lower extremities, 50 in upper

32
Q

ALS affects the (upper motor neuron/lower motor neuron)

A

both

33
Q

___ cells in the thymus are linked to myasthenia gravis

A

Myoid

34
Q

DMD is a defect in the ___ called a ___ lesion

A

basement membrane; delta

35
Q

Truncated dystrophin leads to ___; absence leads to ___

A

Beckers; Duchenne

36
Q

One genetic option for DMD/BMD is to upregulate ___, which is 7% shorter than dystrophin

A

utrophin

37
Q

Progressive scoliosis which progresses rapidly past 40 degrees is a concern in ___

A

DMD